» Articles » PMID: 35735025

Incidence and Risk Factors of Postoperative Nausea and Vomiting in Lung Cancer Patients Following Lobectomy and Application of Analgesic Pumps

Overview
Journal J Int Med Res
Publisher Sage Publications
Specialty General Medicine
Date 2022 Jun 23
PMID 35735025
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the occurrence rate and risk factors of postoperative nausea and vomiting (PONV) in lung cancer patients following lobectomy and application of analgesic pumps.

Methods: This retrospective study reviewed clinical data from patients that had undergone lobectomy for lung cancer under general anaesthesia. The risk factors of PONV were analysed using binary logistic regression models.

Results: A total of 203 patients (97 females) were enrolled. The rate of PONV was 29.6% (60 of 203 patients) for all patients, 42.3% (41 of 97 patients) for female patients and 17.9% (19 of 106 patients) for male patients. Female patients undergoing thoracotomy (odds ratio [OR] 7.770, 95% confidence interval [CI] 1.747, 34.568) or having surgery durations ≥120 min (OR 4.493, 95% CI 1.502, 12.851) were significantly more susceptible to PONV. The risk of PONV in female patients that received postoperative dolasetron (100 mg, once a day) was significantly lower (OR 0.075, 95% CI 0.007, 0.834). For male patients, the risk of PONV was significantly lower in those with a body mass index ≥24 kg/m (OR 0.166; 95% CI 0.035, 0.782).

Conclusion: Female and male patients have different risk factors for PONV following lobectomy for lung cancer and application of analgesic pumps.

Citing Articles

No Difference in Postoperative Recovery Outcomes Between Opioid-Free and Opioid-Sparing Anesthesia Under Multimodal Analgesic Protocol for Video-Assisted Thoracoscopic Surgery: A Propensity Score Matching Cohort Study.

Kim M, Huh J, Choi H, Hwang W J Clin Med. 2024; 13(21).

PMID: 39518720 PMC: 11546950. DOI: 10.3390/jcm13216581.


Early Ambulation Following Lung Resection Surgery: Impact on Short-term Outcomes in Patients with Lung Cancer.

Kurata K, Nagata Y, Oki K, Ono K, Miyake T, Inui K Phys Ther Res. 2024; 27(1):42-48.

PMID: 38690530 PMC: 11057388. DOI: 10.1298/ptr.E10277.


Comparative efficacy of prophylactic protocols in reducing perioperative nausea and vomiting during video-assisted thoracoscopic radical resection of lung cancer.

Zhang W, Shen Z, Jiang J, Zhu S, Zhang P, Chen S Sci Rep. 2024; 14(1):9818.

PMID: 38684769 PMC: 11059372. DOI: 10.1038/s41598-024-59687-z.

References
1.
Momeni M, Crucitti M, De Kock M . Patient-controlled analgesia in the management of postoperative pain. Drugs. 2006; 66(18):2321-37. DOI: 10.2165/00003495-200666180-00005. View

2.
Jolley S . Managing post-operative nausea and vomiting. Nurs Stand. 2002; 15(40):47-52; quiz 53-5. DOI: 10.7748/ns2001.06.15.40.47.c3044. View

3.
Nitahara K, Sugi Y, Shono S, Hamada T, Higa K . Risk factors for nausea and vomiting following vitrectomy in adults. Eur J Anaesthesiol. 2006; 24(2):166-70. DOI: 10.1017/S0265021506001360. View

4.
Wang G, Volkow N, Logan J, Pappas N, Wong C, Zhu W . Brain dopamine and obesity. Lancet. 2001; 357(9253):354-7. DOI: 10.1016/s0140-6736(00)03643-6. View

5.
Gan T, Belani K, Bergese S, Chung F, Diemunsch P, Habib A . Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting. Anesth Analg. 2020; 131(2):411-448. DOI: 10.1213/ANE.0000000000004833. View